Clinical Trials Directory

Trials / Unknown

UnknownNCT02642484

Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

* Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. * Quinine was suggested for treatment of patients with muscle cramps in patients with liver cirrhosis. However, thrombocytopenia, cardiac arrhythmias and cinchonism are serious side effects.

Detailed description

• The aim of the study was to assess the efficacy and safety of Gabapentin in the treatment of muscle cramps in patients with liver cirrhosis.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinGapapentin twice daily
DRUGCalcium Carbonatecalcium carbonate twice daily

Timeline

Start date
2018-12-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2015-12-30
Last updated
2018-01-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02642484. Inclusion in this directory is not an endorsement.